Griffin Stephen D.
President and CEO
Griffin Stephen D. has filed 3 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Jun 5, 2026.
On the most recent filing, Griffin Stephen D. is listed as President and CEO at Anika Therapeutics, Inc. Inside the rolling window, Griffin Stephen D. reported 1 open-market purchase totaling $150K in ANIK and no open-market sales.
Companies traded
Other insiders at ANIK
Insider Buying
$150K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Griffin Stephen D. made?
Griffin Stephen D. has filed 3 SEC Form 4 filings (6 transaction rows) across 1 company since 2026.
Which companies does Griffin Stephen D. trade?
Griffin Stephen D. has filed SEC Form 4 disclosures for 1 company, including ANIK.
When was Griffin Stephen D.'s most recent SEC Form 4 filing?
Griffin Stephen D.'s most recent SEC Form 4 filing on Tracefour is dated Jun 5, 2026.
What is Griffin Stephen D.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Griffin Stephen D. is listed as President and CEO.
What is Griffin Stephen D.'s total buy and sell value in the current window?
Inside the rolling retention window, Griffin Stephen D. bought $150K and sold $0 based on SEC Form 4 filings.
What was Griffin Stephen D.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 12,200 ANIK shares on 2026-04-30, worth $150K, per SEC Form 4 filings.